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Edited by Barry HalliwellAbstract In mitochondrial apoptosis, the formation of cyto-
chrome c–cardiolipin complex ([CL-cyt c]) with peroxidase prop-
erties is an early event in the cascade of reactions that leads to
cell death. Herein, we report the synthesis of a new prodrug,
(2-hydroxyamino-vinyl)-triphenyl-phosphonium (HVTP), which
compartmentalizes exclusively into mitochondria, undergoes a
[CL-cyt c]-catalyzed bioactivation to nitric oxide (NO), inhibits
peroxidase activity, and protects cells from apoptosis.
 2008 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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Elimination of irreparably damaged or genetically pre-
determined cells by apoptosis heavily relies on mitochondria.
Permeabilization of mitochondrial membrane and release of
pro-apoptotic factors into the cytosol designates a point-of-
no-return followed by degradation of intracellular constituents
and subsequent clearance of damaged cells by phagocytes. This
major function of mitochondria as death-triggering machines is
impossible without generation of reactive oxygen species and a
dramatic change of the normal electron transporting function
of cytochrome c (cyt c) to that of a peroxidase upon binding
to a mitochondria-speciﬁc phospholipid, cardiolipin (CL) [1].
The central role of the [CL-cyt c] complex as a peroxidase
implies that inhibition of its activity may be used for regulation
of apoptotic cell death. NO readily inhibits peroxidases by
forming iron-nitrosyl complexes or by interacting with the
reactive intermediates at the heme-site or protein immobilized
radical sites [2,3]. Moreover, NO impedes lipid peroxidation
via interception of lipid radicals [3]. However, the concentra-
tions of endogenous NO in mitochondria are not suﬃcient
to eﬀectively inhibit the [CL-cyt c]-dependent peroxidase path-
way. Triphenylphosphonium derivatization ((Ph)3P
+–) has
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doi:10.1016/j.febslet.2008.01.047compounds into mitochondria [4,5]; we employed this strategy
to synthesize (2-hydroxyamino-vinyl)-triphenyl-phosphonium
(HVTP) as a potential substrate of [CL-cyt c]. This is based
on previous studies by us and others demonstrating one-
electron oxidation of oximes to iminoxyl radicals by iron
complexes as the ﬁrst step in their metabolism to NO [6,7].
Here, we report that HVTP compartmentalizes exclusively into
mitochondria, undergoes a [CL-cyt c]-catalyzed bioactivation
to NO, inhibits peroxidase activity, and protects cells from
apoptotic death.2. Methods
2.1. Preparation of HVTP
An aqueous solution (10 ml) of (2-oxo-ethyl)-triphenyl-phospho-
nium chloride (I; 1.04 g; Acros, Inc.; Geel, Belgium) and hydroxyl-
amine hydrochloride (0.5 g) was titrated with HCl to pH 6.2 and
then incubated for 14 h at 4 C. The ﬁnal reaction solution was satu-
rated with sodium chloride and extracted with ethyl acetate
(3 · 15 ml). The uniﬁed organic layers were dried over anhydrous
Na2SO4, ﬁltered, mixed with n-hexane until the appearance of turbid-
ity, and kept at 20 C for 12 h. The pale yellow crystals formed
(0.57 g; HVIP >98 %) were ﬁltered and HVTP was puriﬁed by C18
HPLC.
2.2. HPLC analysis of HVTP
Analytical and semi-preparative isocratic separations of HVTP were
achieved with 50% methanol containing 20 mM LiCLO4 at a ﬂow rate
of 1 ml per min on a 4.6 · 250 mm Alltima (5 lm; C-18) and
10 · 250 mm Econosil (10 lm; C-18) column, respectively (Alltech
Associates, Inc., Deerﬁeld, IL). Detection of HVTP was performed
with a SPD-M10Avp photodiode array detector (Shimadzu, Kyoto,
Japan) following the speciﬁc UV spectrum of the triphenylphospho-
nium function (kmax = 224 nm; 265 nm), and by mass spectrometry
(LXQ Linear Ion Trap Mass Spectrometer; Thermoelectron, San Jose,
CA). HVTP was eluted as a single peak with purity of 0.99, as
calculated with EZChrom 4.2 (Class VP/PDA; Shimadzu Inc., Colum-
bia, MD). In separations with mobile phases with varying polarity (35–
50% methanol), this index remained constant, suggesting that HVTP
eluted as a homogenous peak. MS, MS–MS and NMR data support-
ing the structure of HVTP are included in Supplementary information.
HPLC analysis of HVTP in isolated mitochondria and cytosol was
carried out after precipitation of proteins with CH3CN (50%; 30 min
at 0–4 C; centrifugation, 5 min · 12000 · g).
2.3. EPR analysis
EPR experiments were carried out with a Jeol JES-FA100 spectro-
meter (Tokyo, Japan) at room temperature. Spectrometer settings
were: ﬁeld center, 335.237 mT; sweep width, 5 mT; modulation width,ation of European Biochemical Societies.
Fig. 1. HVTP undergoes [CL-cyt c]-catalyzed oxidation to NO and
inhibits peroxidase activity. Reactions were carried out at 25 C in
25 mM sodium-phosphate buﬀer (pH 7.0) containing DTPA (100 lM).
Cyt c, carboxy-PTIO, HVTP, and H2O2 were used at concentrations of
5, 10, 50, and 200 lM, respectively. (A, B) HVTP, cyt c and H2O2; 1–3:
DOPC(500 lM)-liposomes; 5–7: CL (125 lM)-containing DOPC
(375 lM) liposomes. EPR spectra were recorded 1 min (traces 1 and
5), 10 min (traces 2 and 6), and 30 min (traces 3 and 7) after addition of
H2O2. Spectrum 8 was obtained after subtraction of the spectrum of
carboxy-PTIO from spectrum 7. Spectra 4 and 9 represent computer
simulations of the spectra of carboxy-PTIO and IMND, respectively.
(C) EPR-monitored kinetics of IMND formation by HVTP, CL-
containing DOPC liposomes, cyt c and H2O2 as a function of CL. In B,
arrow indicates the spectral line used to monitor the formation of
IMND. (D) Oligomerization of cyt c by H2O2 (25 lM) and CL
(125 lM)-containing liposomes in the absence and in the presence of
HVTP (a, b, c, d and e – 25, 50, 100, 200 and 400 lM, respectively).
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EPR spectra simulation were performed with a computer program
created by Philip D. Morse II and Richard Reiter (ESR Simulation
System 2.01, Scientiﬁc Software Services, IL).
2.4. Preparation of CL-containing liposomes
Liposomes containing dioleoyl-L-a-phosphatidylcholine (DOPC;
0.5 mM) and 1,1 02,2 0-tetraoleoyl cardiolipin (DOPC-CL; 025 mM
DOPC and 0.25 mM cardiolipin) were prepared by sonication
(10 · 5 s; relaxation time, 2 min; 0–4 C) with ultrasound in 25 mM
sodium phosphate buﬀer (pH 7.0) containing 100 lM DTPA.
2.5. Cell culture
MEC+/+ and MEC/ (courtesy of Dr. X. Wang, University of
Texas, Dallas) were maintained in Dulbecco modiﬁed Eagle medium
supplemented with 15% fetal bovine serum, 25 mmol/L HEPES,
50 mg/L uridine, 110 mg/L pyruvate, 2 mmol/L glutamine, 1· non-
essential amino acids, 0.05 mmol/L 2-mercaptoethanol, 100 U/L
penicillin, and 100 mg/L streptomycin.
2.6. Biomarkers of apoptosis
Cells (0.15 · 106) were seeded in 6-well plates and let attached over-
night. Cells were preincubated with HVTP for 4 h, washed with PBS
(3 · 1 mL), and then treated with actinomycin D (ActD, 100 ng/ml)
to induce apoptosis. At the end of incubation (18 h), the cells were
harvested by trypsinization, washed twice with PBS, and caspase-3/7
activity in cell lysates was measured with a chemiluminescence
Caspase-Glo 3/7 assay kit obtained from Promega (Madison, WI).
Luminescence was determined at 25 C with a ML1000 luminescence
plate reader (Dynatech Laboratories, Chantilly, VA). Caspase-3/7
activity was expressed as luminescence arbitrary units per milligram
of protein produced within 1 h incubation.
PS externalization was determined with an annexin V–FITC apop-
tosis detection kit (BioVision, Mountain View, CA). Collected cells
were resuspended in the binding buﬀer and incubated with the annexin
V–FITC conjugate and propidium iodide for 5 min in the dark. Cell
ﬂuorescence was analyzed with a FACScan ﬂow cytometer (Beckton-
Dickinson) with simultaneous monitoring of green ﬂuorescence for
annexin V–FITC (530 nm, 30 nm band-pass ﬁlter, FL-1) and red
ﬂuorescence associated with propidium iodide (long-pass emission
ﬁlter that transmits >650 nm light, FL-3). For each sample, 10,000
events were recorded and analyzed.
2.7. Isolation of mitochondria
Cells (1 · 106) were seeded in 100 mm cell culture dishes and let
attached overnight. Cells were incubated with HVTP (50 lM; 0.5–
4 h) then collected by trypsinization and washed twice with PBS. Mito-
chondria fraction was isolated by diﬀerential centrifugation. Brieﬂy,
cells were suspended in mitochondria isolation buﬀer (MIB, 210 mM
mannitol, 70 mM sucrose, 10 mM HEPES, 1 mM EDTA, pH 7.4)
and lysed by Dounce homogenization. Unbroken cells, nuclei and deb-
ris were removed by 10 min centrifugation at 700 · g at 4 C. A mito-
chondria rich fraction was obtained by 10 min centrifugation at
5000 · g and washed twice with MIB.
2.8. Assessment of NO production
Cells (0.15 · 106) were seeded in 6-well plate and let attached over-
night. HVTP (100 lM) was added 4 h prior to induction of apoptosis
by actinomycin D (ActD, 100 ng/ml). At the end of incubation with
ActD (18 h), the cells were incubated with DAF-2-DA (10 lM for
30 min at 37 C), harvested by trypsinization, washed twice with
PBS, and ﬁxed with 4% paraformaldehyde for 10 min. DAF-2 signal
was determined with FACScan ﬂow cytometer (Beckton-Dickinson,
San Jose, CA) with monitoring green ﬂuorescence (530 nm band-pass
ﬁlter, FL-1 channel). For each analysis, 10000 events were recorded.
2.9. Western blots
Cyt c (1.5 lM) was incubated for 15 min at 25 C in 20 mM HEPES
(pH 7.4) containing CL (12.5 lM)/DOPC (125 lM) liposomes. There-
after, samples were transferred to a water bath (37 C) and 4 aliquots
of 25 lMH2O2 were added with a time interval of 15 min. After termi-
nation of the reactions with catalase (ﬁnal activity, 500 U/ml), equal
amounts of protein (350 ng) were resolved by SDS–PAGE (12.5%)and transferred on to nitrocellulose membranes. The membranes were
blocked in 5% (w/v) dried milk powder in TBS (Tris-buﬀered saline) at
4 C, incubated with anti-cyt c (1:2000 dilution) overnight, washed
several times, and then incubated with HRP-conjugated goat anti-
mouse antiserum for 60 min at 25 C. The protein bands were visual-
ized by using SuperSignal West Pico Chemiluminescent Substrate
(Pierce).3. Results and discussion
Interaction of [CL-cyt c] with HVTP was monitored in
the presence of H2O2 and 2-(4-carboxyphenyl)-4,5-dihydro-
4,4,5,5-tetra-methyl-1-himidazol-1-yloxy-3-oxide (carboxy-
PTIO), a speciﬁc molecular probe for NO that exhibits a
ﬁve-line EPR spectrum with hyperﬁne splitting constants (in
Gauss) of a1N ¼ a2N ¼ 8:1 (Fig. 1A1). Carboxy-PTIO readily
reacts with NO to form imino nitroxide (IMND) that has a
Fig. 2. HVTP compartmentalizes in mitochondria. HPLC analysis of
mitochondrial (chromatogram 1) and cytosolic (chromatogram 2)
content of HVTP in MEC+/+. Additional experimental details are
provided in Section 2.
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Cyt c, H2O2, HVTP and dioleoyl-L-a-phosphatidylcholine
(DOPC)-liposomes lacking CL did not change the spectrum
of carboxy-PTIO to any signiﬁcant extent (Fig. 1A1–3; A4,
computer simulation of the spectrum of carboxy-PTIO). In
the presence of CL, however, the magnitude of the EPR spec-
trum of carboxy-PTIO decreased with concomitant appear-
ance of a seven-line EPR spectrum that was assigned to
IMND (Fig. 1A5–8; B9, computer simulation of the spectrum
of carboxy-PTIO). The initial rate of IMND production
strongly depended on the content of CL (Fig. 1C). As an
end-reaction product of the oxidation of HVTP by [CL-cyt
c], NO was independently identiﬁed chemiluminometrically
using Sievers Nitric Oxide Analyzer (Supplementary informa-
tion). HVTP inhibited typical for peroxidases H2O2-dependent
oligomerization of cyt c ([cyt. c]n; Fig. 1D).
It has been established that cyt c-FeIII interacts with ROOH
to form cyt c-FeIV‚O and RO [8], and that FeIV‚O
complexes oxidize aminoxyls to aminoxyl radicals with con-
comitant generation of NO [6,7,9]. Hence, the [CL-cyt c]-cata-
lyzed release of NO from HVTP may be tentatively explained
by the reaction sequence 1ﬁ 8, where the release of Fe(IV)‚O
following the breakdown of 4 to alkoxyl radical closes the
catalytic cycle (Scheme 1).Scheme 1.
Fig. 3. Cyt c-dependent oxidation of HVTP to NO in MEC. Apoptosis in H
Thereafter, the cells were treated with DAF-2-DA, trypsinized, ﬁxed with for
of DAF-2-triazole was recorded by ﬂow cytometry. Data are presented as mReverse phase HPLC measurements established that in
mouse embryonic cells, HVTP compartmentalized predomi-
nantly into mitochondria (Fig. 2). In these experiments, the
identity of HVTP was conﬁrmed via comparison of the reten-
tion times and the UV spectra of the compounds eluted with
the retention time and the spectrum of authentic HVTP (data
not shown). Recently, Asin-Cayuela et al. conducted detailed
analysis of the uptake of triphenylphosphonium compounds
by mitochondria [5] and concluded that all mitochondrial com-
partments and membranes are enriched with (Ph)3P
+–R; peak-
concentrations of triphenylphosphonium compounds could be
expected in the matrix of non-damaged mitochondria. They
further reported that depolarized mitochondria rapidly release
non-polar triphenylphosphonium compounds back into the
cytosol. Given that mitochondria depolarize during isolation,
the data presented in Fig. 2 may underestimate the total mito-
chondrial content of HVTP in intact cells.VTP-pretreated cells was induced with ActD as described in Section 2.
maldehyde, and green ﬂuorescence reﬂecting NO-dependent formation
eans ± S.D. (n = 3; *P < 0.01 vs. non-treated cells).
Fig. 4. HVTP impedes PS externalization and caspases 3/7 activation in ActD-treated MEC+/+. Data are means ± S.D. (n = 3), *P < 0.01 vs. non-
treated cells.
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[CL-cyt c]. These complexes do not exist in normal mitochon-
dria; instead, they are formed in mitochondria of cells under-
going early apoptosis. The formation of the complexes
becomes possible due to collapse of CL asymmetry in mito-
chondrial membranes and its trans-migration from the inner
to the outer mitochondrial membrane. Whereas typical distri-
bution of mitochondrial components changes markedly dur-
ing apoptosis, we hypothesized that HTVP, even if localized
predominantly in the mitochondrial matrix, gets access to
[CL-cyt c] during apoptosis. To verify this hypothesis, we
have assessed the antiapoptotic potential of HVTP as a func-
tion of the cellular content of cyt c. To this end, we induced
actinomycin D (ActD)-dependent apoptosis in control and
cyt c-deﬁcient mouse embryonic cells (MEC+/+ and
MEC/, respectively). In apoptotic HVTP-loaded MEC+/
+, which exhibit high [CL-cyt c] peroxidase activity [1],
DAF-2 was converted to a benzotriazole, suggesting that
HVTP was metabolized to NO (Fig. 3A). In contrast, no pro-
duction of NO was observed in MEC/ (Fig. 3B).
Although DAF-2 is converted to a ﬂuorescent benzotriazole
by nitric oxide-derived nitrosating species, rather than by
NO [10], it has been successfully used to quantitate NO in in-
tact cells [11]. In parallel, HVTP impeded the activation of
caspases 3/7 and the externalization of phosphatidylserine
(PS), which are two characteristic biomarkers of apoptosis
(Fig. 4A and B).
In conclusion, this work describes a new type of pro-drug
that is selectively targeted to and speciﬁcally activated in mito-
chondria to NO. Since [CL-cyt c]-catalyzed oxidation of phos-
pholipids (LPO) occurs very early in mitochondrial apoptosis,
inhibitors of this process may be used as anti-apoptotic agents.
Positively charged compounds containing an aminoxyl func-
tion may prove particularly useful because of their preferential
compartmentalization into mitochondria and bioactivation to
NO in close proximity to the sites of [CL-cyt c], procaspases,
and induction of lipid peroxidation. Studies to further assess
the pharmacology of HVTP and its structural analogues are
underway.
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